NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $387,000 | -77.9% | 21,718 | -73.2% | 0.01% | -30.0% |
| Q4 2019 | $1,751,000 | +53.7% | 81,125 | +29.7% | 0.01% | +25.0% |
| Q3 2019 | $1,139,000 | -33.0% | 62,556 | +31.0% | 0.01% | -33.3% |
| Q2 2019 | $1,700,000 | +17.1% | 47,766 | +10.5% | 0.01% | -7.7% |
| Q1 2019 | $1,452,000 | +59.0% | 43,210 | +55.6% | 0.01% | +18.2% |
| Q4 2018 | $913,000 | -31.4% | 27,767 | +27.1% | 0.01% | -26.7% |
| Q3 2018 | $1,331,000 | +237.8% | 21,846 | +231.0% | 0.02% | +36.4% |
| Q4 2017 | $394,000 | – | 6,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |